Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,356 | 247 | 97.5% |
| Education | $84.70 | 4 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $585.69 | 34 | $0 (2022) |
| Lilly USA, LLC | $546.75 | 60 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $268.02 | 17 | $0 (2022) |
| Astellas Pharma US Inc | $191.17 | 11 | $0 (2021) |
| AbbVie Inc. | $168.44 | 9 | $0 (2023) |
| GlaxoSmithKline, LLC. | $163.70 | 13 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $159.91 | 12 | $0 (2022) |
| Merck Sharp & Dohme LLC | $154.70 | 12 | $0 (2023) |
| Novo Nordisk Inc | $137.33 | 10 | $0 (2023) |
| Allergan, Inc. | $129.87 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $230.05 | 13 | AbbVie Inc. ($84.05) |
| 2022 | $304.22 | 20 | Lilly USA, LLC ($74.26) |
| 2021 | $298.36 | 21 | Janssen Pharmaceuticals, Inc ($71.44) |
| 2020 | $472.27 | 32 | Amarin Pharma Inc. ($93.26) |
| 2019 | $704.95 | 48 | AstraZeneca Pharmaceuticals LP ($208.74) |
| 2018 | $812.46 | 59 | AstraZeneca Pharmaceuticals LP ($191.86) |
| 2017 | $618.21 | 58 | Lilly USA, LLC ($151.20) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/31/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: VACCINES | ||||||
| 08/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Diabetes | ||||||
| 07/26/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Cardio-renal | ||||||
| 07/06/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 05/25/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Diabetes | ||||||
| 03/30/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), BELSOMRA | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: INSOMNIA | ||||||
| 12/15/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: PRIMARY CARE | ||||||
| 12/02/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Neuroscience | ||||||
| 10/14/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2022 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Respiratory | ||||||
| 09/14/2022 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: Hepatitis B Vaccine | ||||||
| 08/19/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Respiratory | ||||||
| 08/04/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/28/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Diabetes | ||||||
| 06/17/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/09/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/19/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,254 | 1,652 | $224,000 | $105,751 |
| 2022 | 15 | 1,230 | 1,570 | $213,094 | $99,965 |
| 2021 | 18 | 1,424 | 1,952 | $252,029 | $117,329 |
| 2020 | 22 | 1,525 | 1,949 | $209,570 | $93,496 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 221 | 376 | $71,816 | $29,470 | 41.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 190 | 190 | $40,850 | $23,156 | 56.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 220 | 352 | $47,168 | $19,137 | 40.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 82 | 88 | $11,528 | $6,610 | 57.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 41 | 41 | $11,316 | $6,446 | 57.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $6,840 | $5,356 | 78.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 28 | 33 | $10,065 | $5,084 | 50.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 77 | 85 | $7,140 | $2,804 | 39.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 88 | 94 | $4,418 | $2,760 | 62.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 27 | 35 | $3,045 | $1,257 | 41.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 15 | 37 | $2,627 | $1,055 | 40.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 67 | 87 | $2,784 | $802.28 | 28.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $893.00 | $557.84 | 62.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 105 | 141 | $987.00 | $480.81 | 48.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 13 | 13 | $1,053 | $405.20 | 38.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 42 | 42 | $1,470 | $370.60 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 242 | 394 | $75,254 | $30,598 | 40.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 150 | 150 | $32,250 | $18,848 | 58.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 192 | 301 | $40,334 | $15,022 | 37.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 74 | 74 | $20,424 | $11,974 | 58.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 112 | 112 | $14,672 | $7,868 | 53.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 23 | 26 | $7,930 | $4,125 | 52.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 121 | 122 | $5,734 | $3,412 | 59.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $3,840 | $3,165 | 82.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 36 | 40 | $3,360 | $1,433 | 42.7% |
About Dr. Jane Blinzler, MD
Dr. Jane Blinzler, MD is a Internal Medicine healthcare provider based in Harrison, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104822741.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jane Blinzler, MD has received a total of $3,441 in payments from pharmaceutical and medical device companies, with $230.05 received in 2023. These payments were reported across 251 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,356).
As a Medicare-enrolled provider, Blinzler has provided services to 5,433 Medicare beneficiaries, totaling 7,123 services with total Medicare billing of $416,541. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Harrison, OH
- Active Since 06/27/2005
- Last Updated 05/20/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104822741
Products in Payments
- XARELTO (Drug) $257.04
- TRULICITY (Drug) $247.49
- FARXIGA (Drug) $230.64
- JARDIANCE (Drug) $177.28
- VRAYLAR (Drug) $174.52
- Vascepa (Drug) $125.82
- SYMBICORT (Drug) $112.68
- EMGALITY (Drug) $83.69
- JANUVIA (Drug) $83.52
- TRELEGY ELLIPTA (Drug) $79.57
- XIFAXAN (Drug) $70.18
- BEVESPI AEROSPHERE (Drug) $69.75
- MYRBETRIQ (Drug) $66.67
- ANORO (Drug) $60.78
- Myrbetriq (Drug) $59.50
- NURTEC ODT (Drug) $53.44
- Haegarda (Biological) $44.59
- BASAGLAR (Drug) $43.33
- BELSOMRA (Drug) $42.38
- Livalo (Drug) $41.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Harrison
Steven Shrum, Md, MD
Internal Medicine — Payments: $1,583
Cherisse Baldeo, M.d, M.D
Internal Medicine — Payments: $775.69
Dr. Melissa Chu, M.d, M.D
Internal Medicine — Payments: $695.61
Ralph Dagostino, Md, MD
Internal Medicine — Payments: $303.80
Richard Chitsey, M.d, M.D
Internal Medicine — Payments: $299.43
Dr. Waleed Ayesh, Md, MD
Internal Medicine — Payments: $237.40